Search research articles
Contact Us
Filters
Showing results (641-650 of 683) with videos related to
Page
of 69
Sort By:
Journal of Clinical Immunology
|
June 28, 2005
Axon reactive B cells clonally expanded in the cerebrospinal fluid of patients with multiple sclerosis
Yiping Zhang, Reng-Rong Da, Wenzhong Guo, et al.
ACS Infectious Diseases
|
January 6, 2026
Diaryl-Aminoindazole with Extensive In Vitro Mycobactericidal Activity Dependent on Exposure to Reactive Nitrogen Species
Thulasi Warrier, María Martínez-Hoyos, Esther Porras De Francisco, et al.
Elife
|
October 8, 2024
A modified BPaL regimen for tuberculosis treatment replaces linezolid with inhaled spectinamides
Malik Zohaib Ali, Taru S Dutt, Amy MacNeill, et al.
Vaccine
|
May 10, 2012
A trivalent recombinant Ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous SIV challenge
Matthew R Reynolds, Andrea M Weiler, Shari M Piaskowski, et al.
The Journal of Infectious Diseases
|
June 4, 2025
The Kinetics of Bedaquiline Diffusion in Tuberculous Cavities Open a Window for the Emergence of Resistance
Annamarie E Bustion, Jacqueline P Ernest, Firat Kaya, et al.
Toxicology and Applied Pharmacology
|
November 15, 2000
The species-dependent metabolism of efavirenz produces a nephrotoxic glutathione conjugate in rats
A E Mutlib, R J Gerson, P C Meunier, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 30, 2024
Enhancing the therapeutic window for Spectinamide anti-tuberculosis Agents: Synthesis, Evaluation, and activation of phosphate prodrug 3408
Jiuyu Liu, Pradeep B Lukka, Victoria A Ektnitphong, et al.
ACS Infectious Diseases
|
May 30, 2020
Synthesis, Structure-Activity Relationship, and Mechanistic Studies of Aminoquinazolinones Displaying Antimycobacterial Activity
Jessica N Akester, Paul Njaria, Aloysius Nchinda, et al.
Antimicrobial Agents and Chemotherapy
|
March 21, 2022
Combination of Mycobacterium tuberculosis RS Ratio and CFU Improves the Ability of Murine Efficacy Experiments to Distinguish between Drug Treatments
Christian Dide-Agossou, Allison A Bauman, Michelle E Ramey, et al.
Plos Pathogens
|
April 22, 2026
Physiologic recovery of Mycobacterium tuberculosis from drug injury: A molecular study of post antibiotic effect in vitro and in vivo
Jo Hendrix, Reem Al Mubarak, Matthew J Reichlen, et al.
Page
of 69
Search research articles
Search
Showing results (641-650 of 683) with videos related to
Sort By:
Page
of 69
Journal of Clinical Immunology
|
June 28, 2005
Axon reactive B cells clonally expanded in the cerebrospinal fluid of patients with multiple sclerosis
Yiping Zhang, Reng-Rong Da, Wenzhong Guo, et al.
ACS Infectious Diseases
|
January 6, 2026
Diaryl-Aminoindazole with Extensive In Vitro Mycobactericidal Activity Dependent on Exposure to Reactive Nitrogen Species
Thulasi Warrier, María Martínez-Hoyos, Esther Porras De Francisco, et al.
Elife
|
October 8, 2024
A modified BPaL regimen for tuberculosis treatment replaces linezolid with inhaled spectinamides
Malik Zohaib Ali, Taru S Dutt, Amy MacNeill, et al.
Vaccine
|
May 10, 2012
A trivalent recombinant Ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous SIV challenge
Matthew R Reynolds, Andrea M Weiler, Shari M Piaskowski, et al.
The Journal of Infectious Diseases
|
June 4, 2025
The Kinetics of Bedaquiline Diffusion in Tuberculous Cavities Open a Window for the Emergence of Resistance
Annamarie E Bustion, Jacqueline P Ernest, Firat Kaya, et al.
Toxicology and Applied Pharmacology
|
November 15, 2000
The species-dependent metabolism of efavirenz produces a nephrotoxic glutathione conjugate in rats
A E Mutlib, R J Gerson, P C Meunier, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 30, 2024
Enhancing the therapeutic window for Spectinamide anti-tuberculosis Agents: Synthesis, Evaluation, and activation of phosphate prodrug 3408
Jiuyu Liu, Pradeep B Lukka, Victoria A Ektnitphong, et al.
ACS Infectious Diseases
|
May 30, 2020
Synthesis, Structure-Activity Relationship, and Mechanistic Studies of Aminoquinazolinones Displaying Antimycobacterial Activity
Jessica N Akester, Paul Njaria, Aloysius Nchinda, et al.
Antimicrobial Agents and Chemotherapy
|
March 21, 2022
Combination of Mycobacterium tuberculosis RS Ratio and CFU Improves the Ability of Murine Efficacy Experiments to Distinguish between Drug Treatments
Christian Dide-Agossou, Allison A Bauman, Michelle E Ramey, et al.
Plos Pathogens
|
April 22, 2026
Physiologic recovery of Mycobacterium tuberculosis from drug injury: A molecular study of post antibiotic effect in vitro and in vivo
Jo Hendrix, Reem Al Mubarak, Matthew J Reichlen, et al.
Page
of 69